Differential expression of PD-L1 and PD-L2, ligands for an inhibitory receptor PD-1, in the cells of lymphohematopoietic tissues. (Q53722655)

18 May 2018

title

Differential expression of PD-L1 and PD-L2, ligands for an inhibitory receptor PD-1, in the cells of lymphohematopoietic tissues. (English)

1 reference

18 May 2018

7

Tasuku Honjo

1 reference

18 May 2018

Yoshimasa Tanaka

3

0 references

Gordon J. Freeman

5

object named as

Gordon J Freeman

1 reference

18 May 2018

author name string

Masayoshi Ishida

1

1 reference

18 May 2018

Yoshiko Iwai

2

1 reference

18 May 2018

Taku Okazaki

4

1 reference

18 May 2018

Nagahiro Minato

6

1 reference

18 May 2018

publication date

1 October 2002

1 reference

18 May 2018

published in

immunology Letters

1 reference

18 May 2018

volume

84

1 reference

18 May 2018

issue

1

1 reference

18 May 2018

page(s)

57-62

1 reference

18 May 2018

PD-1: an inhibitory immunoreceptor involved in peripheral tolerance

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900142-6

7 January 2021

Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900142-6

7 January 2021

Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900142-6

7 January 2021

Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900142-6

7 January 2021

Lymphoproliferation in CTLA-4-deficient mice is mediated by costimulation-dependent activation of CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900142-6

7 January 2021

The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900142-6

7 January 2021

Co-stimulation in T cell responses.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900142-6

7 January 2021

Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900142-6

7 January 2021

PD-L2 is a second ligand for PD-1 and inhibits T cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900142-6

7 January 2021

Tyrosine phosphatase SHP-2 binding to CTLA-4: absence of direct YVKM/YFIP motif recognition

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900142-6

7 January 2021

Molecular basis of T cell inactivation by CTLA-4

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900142-6

7 January 2021

Cytotoxic T lymphocyte antigen 4 (CTLA-4) engagement delivers an inhibitory signal through the membrane-proximal region in the absence of the tyrosine motif in the cytoplasmic tail

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900142-6

7 January 2021

PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900142-6

7 January 2021

Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900142-6

7 January 2021

Facilitation of beta selection and modification of positive selection in the thymus of PD-1-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900142-6

7 January 2021

Developmentally regulated expression of the PD-1 protein on the surface of double-negative (CD4-CD8-) thymocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2802%2900142-6

7 January 2021

10.1016/S0165-2478(02)00142-6

Identifiers

DOI

1 reference

18 May 2018

PubMed ID

12161284

1 reference

18 May 2018